Statin and Aspirin Use Among Hispanic and Latino Adults at High Cardiovascular Risk: Findings From the Hispanic Community Health Study/Study of Latinos

Autor: Martha L. Daviglus, Franklyn Gonzalez, Donghong Wu, Robert J. Ostfeld, Jianwen Cai, Jocelyn Wilder, Todd A. Lee, Ramon Durazo-Arvizu, Dima M. Qato, Gregory A. Talavera, Samantha A. Reina
Rok vydání: 2016
Předmět:
Male
Gerontology
Disease
030204 cardiovascular system & hematology
0302 clinical medicine
Risk Factors
Cardiovascular Disease
Mexican Americans
Prevalence
Coronary Heart Disease
Medicine
030212 general & internal medicine
Young adult
Original Research
disparities
education.field_of_study
Aspirin
Cuba
Hispanic or Latino
Middle Aged
Health Services
3. Good health
Primary Prevention
Cardiovascular Diseases
South american
Community health
Female
Cardiology and Cardiovascular Medicine
medicine.drug
Adult
cardiovascular risk
Race and Ethnicity
Statin
Adolescent
medicine.drug_class
Population
statins
Young Adult
03 medical and health sciences
Humans
education
Aged
business.industry
Dominican Republic
Puerto Rico
Central America
Odds ratio
South America
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hispanic/Latino
business
Demography
Zdroj: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ISSN: 2047-9980
Popis: Background Despite variations in the prevalence of cardiovascular disease and related risk factors among US Hispanic/Latino adults of diverse backgrounds, there is little information on whether disparities exist in the use of medications for the primary and secondary prevention of cardiovascular disease. We examined the prevalence of statin and aspirin use among diverse US Hispanic/Latino adults at high cardiovascular risk. Methods and Results A multicenter population‐based study, the Hispanic Community Health Study/Study Of Latinos, included a total of 16 415 participants of Mexican, Puerto Rican, Cuban, Dominican, South American, and Central American backgrounds who were aged 18 to 74 years and enrolled between March 2008 and June 2011. Our analyses were limited to 4139 participants considered to be at high cardiovascular risk. Age‐adjusted prevalence of statin and aspirin use was 25% and 44%, respectively, overall but varied by Hispanic/Latino background among those at high cardiovascular risk; statin use was significantly higher ( P CI 1.30–2.31) to 1.30 (95% CI 0.97–1.75), and with a Dominican background, from an odds ratio of 1.45 (95% CI 1.04–2.02) to 1.07 (95% CI 0.75–1.52), in comparison to their counterparts. Conclusions Among Hispanic/Latino adults of diverse backgrounds, statin use was more prevalent among adults with Puerto Rican and Dominican backgrounds at high cardiovascular risk. These differences in statin use were explained, in part, by differences in insurance coverage. These findings have important implications for the prevention of disparities in cardiovascular outcomes within the growing US Hispanic/Latino population.
Databáze: OpenAIRE
Externí odkaz: